A CSF marker of nusinersen treatment response
- PMID: 35396357
- DOI: 10.1038/s41582-022-00656-3
A CSF marker of nusinersen treatment response
Comment on
-
Cathepsin D as biomarker in cerebrospinal fluid of nusinersen-treated patients with spinal muscular atrophy.Eur J Neurol. 2022 Jul;29(7):2084-2096. doi: 10.1111/ene.15331. Epub 2022 May 4. Eur J Neurol. 2022. PMID: 35318785
References
Original article
-
- Schorling, D. C. et al. Cathepsin D as biomarker in CSF of nusinersen-treated patients with spinal muscular atrophy. Eur. J. Neurol. https://doi.org/10.1111/ENE.15331 (2022) - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources